David Charles

The Center for Technology Transfer and Commercialization continued to play a pivotal role in translating the research findings of Vanderbilt faculty into products and companies in 2020 that have the potential to transform many aspects of life, from disease prevention to quality of life-enhancing products. Read More

Spasticity — a consequence of stroke and other disorders of the central nervous system — may be underdiagnosed and undertreated in nursing home residents. Read More

Analysis of data from a clinical trial conducted at Vanderbilt suggests that deep brain stimulation (DBS) administered to patients with very early-stage Parkinson’s disease slowed the progression of rest tremor. The study, published June 29 in Neurology, is significant because it is the first evidence of a treatment that may… Read More

Grant money is available to the Vanderbilt University Medical Center (VUMC) community in order to support programs that increase ambulatory visits conducted via telemedicine. Read More

A consortium led by Vanderbilt University Medical Center (VUMC) researchers has received funding as it makes plans for a multicenter trial that could determine whether deep brain stimulation (DBS) slows the progression of Parkinson’s disease in early-stage patients. Read More

Vanderbilt Heart and Vascular Institute cardiologist Allen Naftilan, M.D., Ph.D., puts a stethoscope to his ears and listens to the heartbeats of patients more than 90 miles away. Read More

Last week, David Charles, M.D., chief medical officer of the Vanderbilt Neuroscience Institute, vice-chair of the Department of Neurology and medical director of Telemedicine, represented Vanderbilt University Medical Center at a White House Convening on Rural Telehealth. Read More

For patients suffering from a stroke, the key to a positive outcome often hinges on how quickly they can receive a brain-saving medical intervention. Read More

In the same way scientists from the Vanderbilt Clinical Neuroscience Scholars (CNS) Program have benefited from their experiences in the clinical setting, an initiative is underway for Psychiatry, Neurology and Neurosurgery residents to have an opportunity to do bench work in the basic science labs. Read More

Vanderbilt anesthesiologists who recently received board certification as neurointensivists include (from left) Nahel Saied, M.D., Roy Neeley, M.D., and Christopher Hughes, M.D. Not pictured are Nathan Ashby, M.D., John Barwise, M.D., Stuart McGrane, M.D., Tracy McGrane, M.D., and Sheena Weaver, M.D. (Photo by Steve Green) After eight… Read More

A long-term Vanderbilt University Medical Center study of deep brain stimulation (DBS) in early-stage Parkinson’s disease has received approval from the Food and Drug Administration (FDA) to continue in a pivotal, phase III, large-scale safety and efficacy trial. Read More

Tammy Frazier has battled cervical dystonia for seven years. (Photo by John Russell) Seven years ago Tammy Frazier noticed an odd tremor in her neck. It wasn’t painful but was very noticeable, with her head almost constantly shaking back and forth. Her primary care provider referred… Read More

After a decade of growth in the Department of Neurology’s residency program, Heather Koons, M.D., is stepping into the role of program director and brings a uniquely international perspective. Read More

Deep brain stimulation used to treat Parkinson’s disease may impair some aspects of language processing, a recent study suggests. Read More

Pioneers of Parkinson’s disease research are gathering at Vanderbilt University Medical Center today to celebrate the end of a study that was an important first step in the quest to find a way to slow the progression of the degenerative movement disorder. Read More